Violations of the proportional hazards assumption in randomized phase III oncology clinical trials.

被引：4
|
作者：
Rahman, Rifaquat
Fell, Geoffrey
Trippa, Lorenzo
Alexander, Brian Michael
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Dana Farber Canc Inst, Dept Biostatist & Computat Biol, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Dana Farber Canc Inst, Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2543
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2543
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Incidence and impact of proportional hazards violations in phase 3 cancer clinical trials.
    Lin, Timothy
    Koong, Alex
    Lin, Christine
    Jaoude, Joseph Abi
    Patel, Roshal
    Kouzy, Ramez
    El Alam, Molly Blue
    Noticewala, Sonal S.
    Sun, Ryan
    Fuller, Clifton Dave
    Thomas, Charles R.
    Mccaw, Zachary
    Ludmir, Ethan B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Deviation from the Proportional Hazards Assumption in Randomized Phase 3 Clinical Trials in Oncology: Prevalence, Associated Factors, and Implications
    Rahman, Rifaquat
    Fell, Geoffrey
    Ventz, Steffen
    Arfe, Andrea
    Vanderbeek, Alyssa M.
    Trippa, Lorenzo
    Alexander, Brian M.
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (21) : 6339 - 6345
  • [3] Characterizing discontinuation and withdrawal from phase III oncology clinical trials.
    Malhi, Navraj
    Gresham, Gillian
    Eigl, Bernhard J.
    Grant, Janice
    Cheung, Winson Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] GRAPHICAL METHODS FOR ASSESSING VIOLATIONS OF THE PROPORTIONAL HAZARDS ASSUMPTION IN COX REGRESSION
    HESS, KR
    [J]. STATISTICS IN MEDICINE, 1995, 14 (15) : 1707 - 1723
  • [5] Factors associated with altmetric attention scores for randomized phase III cancer clinical trials.
    Rooney, Michael Kevin
    Ludmir, Ethan B.
    Fuller, Clifton Dave
    Warner, Jeremy Lyle
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt
    Royston, Patrick
    Parmar, Mahesh K. B.
    [J]. STATISTICS IN MEDICINE, 2011, 30 (19) : 2409 - 2421
  • [7] Assessing violations of the proportional hazards assumption in Cox regression: does the chosen method matter?
    Hiller, Louise
    Marshall, Andrea
    Dunn, Janet
    [J]. TRIALS, 2015, 16
  • [8] Assessing violations of the proportional hazards assumption in Cox regression: does the chosen method matter?
    Louise Hiller
    Andrea Marshall
    Janet Dunn
    [J]. Trials, 16
  • [9] Funding academic oncology clinical trials.
    Seow, H.
    Levine, M. N.
    Bainbridge, D.
    Kowaleski, B.
    Arnold, A. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Racial disparities in oncology clinical trials.
    Desai, Devashish
    Hlaing, Swe Swe
    Goyal, Aakash
    Keogh, Alan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 356 - 356
12345